Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wakansen is a brand of traditional Japanese Kampo (herbal) medicines developed and marketed by Rohto Pharmaceutical. Launched in 2006, the product line consists of various classical herbal formulations adapted for modern over-the-counter (OTC) use in Japan. The most prominent product in the series is the Bofutsushogyosan formulation, which is indicated for the treatment of obesity, abdominal fat, and associated symptoms such as constipation and hypertension-related edema. Other products in the Wakansen line include Keigairengyoto for sinus and skin conditions, Shakuyakukanzoto for muscle cramps, and Goshajinkigan for lower body pain and numbness. These medicines are typically formulated as tablets or granules for oral administration and are regulated as pharmaceutical products (specifically Second-class OTC drugs) in Japan.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wakansen.